Pharmanutra S.p.A.

Milan Stock Exchange PHN.MI

Pharmanutra S.p.A. Shareholders' Equity for the year ending December 31, 2023: USD 60.05 M

Pharmanutra S.p.A. Shareholders' Equity is USD 60.05 M for the year ending December 31, 2023, a 10.16% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Pharmanutra S.p.A. Shareholders' Equity for the year ending December 31, 2022 was USD 54.51 M, a 6.22% change year over year.
  • Pharmanutra S.p.A. Shareholders' Equity for the year ending December 31, 2021 was USD 51.32 M, a 11.35% change year over year.
  • Pharmanutra S.p.A. Shareholders' Equity for the year ending December 31, 2020 was USD 46.09 M, a 45.98% change year over year.
  • Pharmanutra S.p.A. Shareholders' Equity for the year ending December 31, 2019 was USD 31.57 M, a 12.87% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Loading...
Milan Stock Exchange: PHN.MI

Pharmanutra S.p.A.

CEO Mr. Andrea Lacorte
IPO Date July 18, 2017
Location Italy
Headquarters Via delle Lenze 216/B
Employees 112
Sector Health Care
Industries
Description

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. Its products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. The company distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.

Similar companies

ELN.MI

EL.En. S.p.A.

USD 11.22

0.24%

TNXT.MI

Tinexta S.p.A.

USD 7.98

1.79%

DGV.MI

Digital Value S.p.A.

USD 23.60

4.01%

SES.MI

SeSa S.p.A.

USD 59.41

-1.86%

WIIT.MI

Wiit S.p.A.

USD 19.07

-1.00%

StockViz Staff

January 15, 2025

Any question? Send us an email